Pharma industry change – Sanofi
As if to emphasise what my last post said, today came an announcement from Sanofi, the French pharma company, that they are buying Chattem for $1.9bn. Chattem provides over-the-counter drugs like Gold Bond or Selsun Blue. 
What’s the rationale for this? Probably Sanofi wants to become less reliant on the blockbuster patented drug business.
Comments
Leave a Reply

